Skip to main content


Treatment of breast cancer with epigenetic specific tools The partners of the TREATBEST consortium are joining forces in order to leverage disruptive science in the field of personalized breast cancer treatment. The final product will be a CE-marked IVD test predicting the treatment benefit for patients with triple-negative breast cancer,...
Read More


Identification of drug candidates and biomarkers for immunotherapy (cancer and autoimmune diseases) IT-Targets project aims to identify innovative drugs candidates and biomarkers for cancer immunotherapy and auto-immune diseases in order to improve the response of patients to immunotherapy. The strategy is based on sampling human clinical samples, purify the different...
Read More


Optimization of the treatment with HepaMune in fibro-inflammatory chronic liver diseases The aim of the IMPROVE project is to develop a new cell therapy product that will be used for the treatment of fibro-inflammatory chronic liver diseases. The objective is to develop a product exhibiting increased immuno-modulatory and anti-inflammatory potential,...
Read More


Development and validation of a local treatment for cervix cancer resulting from human papillomavirus infection The main objective of the project is the development of an effective and safe local treatment, of the lesions of the cervix induced by HPV infection. This project results from the identification of a medical...
Read More


Development of inhaled synergetic combinations for the treatment of resistant respiratory infections The aim of BioFiNa is to develop inhaled synergetic combinations for the treatment of resistant respiratory infections. The development of germs which are increasingly resistant to antibiotics is a major public health problem. The arsenal of available antibacterials...
Read More


Development and validation of new molecules to restore the immune response against cancer cells Immunotherapy, based on therapeutic vaccination against antigens expressed by cancer cells, is at the present time a very promising approach. Its application is limited, however, due to mechanisms of immune suppression that are critical to control...
Read More


Discovery of new targets for the treatment of Parkinson’s disease The HOPE 4 PD project aims to validate two G protein coupled receptors (GPCRs), whose expression is altered in the striatum of patients with Parkinson's disease, as targets of drugs to treat neuro-degenerative diseases, Parkinson's disease being the first indication....
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!